Death due to haemorrhage (bleeding) is a preventable death. Yet 30-40% of people in a civilian setting die as a result of bleeding to death. In a military setting 90% of casualties with potentially survivable injuries die due to haemorrhage. This project will specifically target this clinical need, through the design, construction and testing of this portable efficacious haemostatic agent/dressing to control bleeding. We are employing potent snake venom proteins to bring about rapid and stable blood clot formation in combination with biomaterials to target specific wound types.

  Are you interested in a PhD at the AIBN? Click here, and start your journey today. 

Related sources

Funding boost brings life-saving 'venom' gel device a step closer

Deadly snakes could save your life


biochemistry, snake venom, hydrogel, biomaterials, biomedical research,

Supervisor name/s

Professor Alan Rowan
AIBN Institute Director
Rowan Group

Dr Amanda Kijas
Senior Research Fellow
Rowan Group

Supervisor email/s